Article
Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma
22 Mar 2005
Abstract excerpt
The utilisation of antitumour T cells induced by cancer vaccination with HER-2 peptides or antibodies (Herceptin) against HER-2, as immunotherapy for oesophageal cancer, is a novel and attractive approach. It is important to clarify the frequencies of HER-2 expression and gene amplification in patients with oesophageal squamous cell carcinoma (SCC) and to evaluate the relationship between HER-2 status and HLA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
